The study, titled “GenAI-Powered Framework for Reliable Sentiment Labeling in Drug Safety Monitoring,” published in Applied ...
Neuropacs™ Corp., an innovator in AI-enabled neurological imaging, today announced that the U.S. Food and Drug Administration has granted De Novo classification to neuropacs™, a diffusion MRI-based ...
Apr 15, 2026 // AI governance requires better workforce data, with partnerships helping governments measure talent flows and ...
A new study shows that self-supervised artificial intelligence may offer a more practical path for detecting concrete cracks ...
The Company launched a successful maiden drill program in November 2024. It then reported strong drill results (reported here ...
Identification of each animal in a collective becomes possible even when individuals are never all visible simultaneously, enabling faster and more accurate analysis of collective behavior.
Completed randomization in REMAIN-1 Pivotal Cohort; topline 6-Month data expected in early Q4 2026Received favorable FDA feedback on De Novo ...
Background/aims Ocular surface infections remain a major cause of visual loss worldwide, yet diagnosis often relies on slow ...
Vietnam Investment Review on MSN
Breakthrough Prize announces 2026 laureates
LOS ANGELES, April 19, 2026 /PRNewswire/ -- The Breakthrough Prize Foundation today announced the winners of the 2026 Breakthrough Prizes, honoring scientists whose discoveries are significantly ...
A 2026 informational overview of Herz P1 Smart BPM FDA 510K clearance, wrist blood pressure monitor accuracy considerations, irregular heartbeat detection features, at-home cardiovascular tracking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results